8 completed, 3 terminated, 2 withdrawn. 13 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 13 | Completed 8, Terminated 3, Withdrawn 2 |
Follow Recurrent Marginal Zone Lymphoma: new trials by email Literature Review of Recurrent Marginal Zone Lymphoma trials Research Report on Recurrent Marginal Zone Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma | Not applicable | Withdrawn | Fred Hutchinson Cancer Center | 2015-02-01 | 2015-05-07 | |
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma plerixafor, filgrastim, etoposide - Adult Acute Lymphoblastic Leukemia in Remission, Adult Grade III Lymphomatoid Granulomatosis | Not applicable | Terminated | Case Comprehensive Cancer Center | 25 | 2011-10-01 | 2019-06-14 |
| Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma bortezomib, filgrastim, autologous hematopoietic stem cell transplantation - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 23 | 2011-07-01 | 2021-05-10 |
| Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer palifermin, flow cytometry, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Martin, Paul | 6 | 2010-09-01 | 2014-04-02 |
| Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies plerixafor, filgrastim, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Terminated | Fred Hutchinson Cancer Center | 1 | 2010-06-01 | 2017-06-28 |
| Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Not applicable | Completed | Roswell Park Cancer Institute | 62 | 2009-01-14 | 2019-11-13 |
| High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors etoposide, cyclophosphamide, carmustine - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission | Not applicable | Completed | Roswell Park Cancer Institute | 174 | 2006-06-29 | 2021-04-22 |
| Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant lithium carbonate, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Fred Hutchinson Cancer Center | 20 | 2006-06-01 | 2017-03-07 |
| Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia arsenic trioxide, laboratory biomarker analysis - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma | Not applicable | Terminated | National Cancer Institute (NCI) | 25 | 2001-01-01 | 2013-02-01 |
| Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia | Not applicable | Completed | Fred Hutchinson Cancer Center | 160 | 2000-12-01 | 2020-01-21 |
| Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Fred Hutchinson Cancer Center | 55 | 1999-11-01 | 2019-09-10 |
| Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma chemotherapy, total-body irradiation, peripheral blood stem cell transplantation - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Not applicable | Completed | Fred Hutchinson Cancer Center | 63 | 1997-09-01 | 2019-12-27 |
Leukemia, Lymphocytic, Chronic, B-Cell (13) · Lymphoma, B-Cell, Marginal Zone (13) · Lymphoma, Follicular (13) · Lymphoma, Non-Hodgkin (13) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (12) · Burkitt Lymphoma (11) · Lymphoma, Large B-Cell, Diffuse (11) · Lymphoma, Large-Cell, Immunoblastic (11) · Lymphoma, Mantle-Cell (11) · Lymphoma, T-Cell, Cutaneous (11) · Leukemia, Hairy Cell (10) · Mycosis Fungoides (10) · Sezary Syndrome (10) · Hodgkin Disease (9) · Multiple Myeloma (9)
Chronic Disease (13) · Disease Attributes (13) · Hematologic Diseases (13) · Hemic and Lymphatic Diseases (13) · Immune System Diseases (13) · Immunoproliferative Disorders (13) · Leukemia (13) · Leukemia, B-Cell (13) · Leukemia, Lymphoid (13) · Lymphatic Diseases (13) · Lymphoma (13) · Lymphoma, B-Cell (13) · Lymphoproliferative Disorders (13) · Neoplasms (13) · Neoplasms by Histologic Type (13)
Peripheral Blood Stem Cell Transplantation (5) · Whole-Body Irradiation (5) · Cyclosporine (3) · Etoposide (3) · Filgrastim (3) · Granulocyte Colony-Stimulating Factor (3) · Melphalan (3) · Mycophenolic Acid (3) · fludarabine phosphate (3) · Carmustine (2) · plerixafor (2) · Antilymphocyte Serum (1) · Arsenic Trioxide (1) · Bortezomib (1) · Busulfan (1)
Fred Hutchinson Cancer Center (6) · Roswell Park Cancer Institute (3) · Barbara Ann Karmanos Cancer Institute (1) · Case Comprehensive Cancer Center (1) · Martin, Paul (1) · National Cancer Institute (NCI) (1)
United States (12) · Germany (3) · Italy (2)
David Maloney (2) · Paul Martin (2) · Philip McCarthy (2) · Ann Woolfrey (1) · Brenda Sandmaier (1) · Divaya Bhutani, M.D. (1) · George Chen (1) · Luis Isola (1) · Navneet Majhail, MD (1) · William Bensinger (1)
P30CA015704 (4), P01CA018029 (1), P30CA016056 (1), P30CA022453 (1), P30CA043703 (1), R01CA085748 (1)